PuraMatrix® is the first commercial synthetic extracellular matrix (ECM) scaffold, enabling cells to be cultured in carefully controlled microenvironments for life science research, pharmaceutical drug discovery and bioproduction. PuraMatrix® enhances valuable and expensive cell assays that predict proper drug interactions and metabolism. In particular, PuraMatrix® has improved cell assays in which one or more types of cells form complex structures (such as spheroids, networks, synapses, vascularization). The result is improved models for in vivo and in vitro research and testing, increasing predictability and reducing the cost of drug discovery research. Click here to review PuraMatrix® Guidelines for Use.
1 Wellman Center for Photomedicine Massachusetts General Hospital,
Harvard Medical School,
2 Thayer School of Engineering, Dartmouth College,
3 Department of Dermatology, Harvard Medical School
This video demonstrates how to encapsulate and culture cancer cells in PuraMatrix®.
Culture, release, and analysis of human neural progenitor cells utilizing PuraMatrix®.
PuraMatrix® in the creation of 3-D hydrogel systems for the production of microfabricated neural cell and tissue cultures.